ALXO Delta Exposure (DEX)

Net delta exposure for ALX Oncology Holdings Inc (ALXO) options was $471.22K per 1% move at the Nov 4, 2026 close. It has been positive on 20 of the last 20 trading days. That is its highest reading in 12 weeks.

Upgrade to unlock Call Wall, Put Wall, and multiple expiration dates.

Upgrade now

Delta Exposure by Strike

Showing results for ALXO, 2026-11-20(m), calls & puts

       

Delta Exposure Stats

Showing results for ALXO, 2026-11-20(m), calls & puts



Net Delta Exposure by Expiration

Showing results for ALXO, 2026-11-20(m), calls & puts. View all expiries

       
Expiration Net DEX Call DEX Put DEX Call Wall Put Wall

ALXO Delta Exposure FAQ

What is delta exposure (DEX)?

Delta exposure estimates the dollar value of shares option dealers hold or owe as a hedge, per 1% move in the underlying.

Is ALXO delta exposure positive or negative?

ALX Oncology net delta exposure was positive on Nov 4, 2026, at $471.22K. It has been positive on 20 of the last 20 trading days.

How has ALXO delta exposure changed recently?

ALX Oncology net delta exposure went from $119.56K on Oct 7, 2026 to $471.22K on Nov 4, 2026. See the ALXO delta exposure history for a longer view.

What is ALX Oncology Holdings Inc?

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials.

Give feedback on this chart